KMT2A and diabetes mellitus: In an animal model of type 2 diabetes mellitus (DM2) consisting of obese diabetic db/db mice, β‐cell‐specific Trx‐1 overexpression suppressed progressive β‐cell failure (Yamamoto et al., 2008).